Seeing Is Believing
Currently out of the existing stock ratings of Graham Doyle, 15 are a BUY (30%), 22 are a HOLD (44%), 13 are a SELL (26%).
Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 36.51% that have a potential upside of 6.1% achieved within 72 days.
Graham Doyle’s has documented 80 price targets and ratings displayed on 7 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on PHG, Koninklijke Philips NV ADR at 03-Aug-2026.
Analyst best performing recommendations are on GEHC (GE HEALTHCARE TECHNOLOGIES).
The best stock recommendation documented was for GEHC (GE HEALTHCARE TECHNOLOGIES) at 5/5/2025. The price target of $73 was fulfilled within 7 days with a profit of $3.79 (5.48%) receiving and performance score of 7.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Aug-2024
1 months 29 days ago
(06-Aug-2026)
7/13 (53.85%)
$-7.2 (-32.01%)
627
Hold Since 28-Feb-2024
2 months ago
(05-Aug-2026)
12/17 (70.59%)
$-8.4 (-37.35%)
305
Hold Since 17-Mar-2025
$30
$-0.04 (-0.13%)
$35
4 months 24 days ago
(11-May-2026)
5/6 (83.33%)
$0.9 (3.09%)
16
Buy Since 09-Dec-2025
$39
$8.96 (29.83%)
9 months 26 days ago
(09-Dec-2025)
0/1 (0%)
$6 (18.18%)
Buy Since 29-Jan-2025
$37.5
$7.46 (24.83%)
11 months 21 days ago
(14-Oct-2025)
2/4 (50%)
$2.24 (6.35%)
762
Which stock is Graham Doyle most bullish on?
Which stock is Graham Doyle most reserved on?
What Year was the first public recommendation made by Graham Doyle?